INDIA IMMUNO ONCOLOGY DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Cancer Type
     • Market Snapshot, By Distribution Channel
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Drivers
   • Restraints
   • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Product Approval
   • Collaboration/Merge/Acquisition
   • Regulatory Landscape
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Epidemiology
   • Robust Pipeline Analysis

4. India Immuno-Oncology Drugs Market, By Drug Type, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022– 2033
     • Segment Trends
   • Immune Checkpoint Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
     • Segment Trends
       • Nivolumab
       • Atezolimumab
       • Pembrolizuma
       • Durvalumab
   • Monoclonal Antibodies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
     • Segment Trends
       • Rituximab
       • Trastazumab
       • Bevacizumab
       • Nimotuzumab
       • Pertuzumab
       • Ado-Trastuzumab Emtansine
   • Cancer Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
     • Segment Trends
       • Gardasil
       • Cervarix

5. India Immuno-Oncology Drugs Market, By Cancer Type, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Lung Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Blood Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Breast Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Ovarian Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Cervical Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Colorectal Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Stomach Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Head & Neck Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)

6. India Immuno-Oncology Drugs Market, By Distribution Channel, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)

7. Competitive Landscape

   • Heat Map Analysis
   • Market Share Analysis
   • Company Profile
     • Amgen Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • F. Hoffmann-La Roche AG.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Intas Pharmaceuticals Ltd.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • AstraZeneca plc
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Mylan N.V.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Dr. Reddy's Laboratories
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Bristol - Myers Squibb
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Merck & Co., Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • BIOCAD-Biotechnology company
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Reliance Life Sciences
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Biocon Limited
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Hetero Drugs Limited
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
   • Analyst Views

8. Section

   • References
   • Research Methodology
   • About Us